- 全部删除
- 您的购物车当前为空
CGP37157 (7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one) 是一种 Na+/Ca2+ 交换抑制剂,抑制 Na+ 诱导的豚鼠心脏线粒体中 Ca2+ 的释放,IC50 为 0.8 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
CGP37157 (7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one) 是一种 Na+/Ca2+ 交换抑制剂,抑制 Na+ 诱导的豚鼠心脏线粒体中 Ca2+ 的释放,IC50 为 0.8 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 398 | In stock | |
10 mg | ¥ 697 | In stock | |
25 mg | ¥ 1,240 | In stock | |
50 mg | ¥ 2,137 | In stock | |
100 mg | ¥ 3,422 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 448 | In stock |
CGP37157 相关产品
产品描述 | CGP37157 (7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one) is a Na+/Ca2+ exchanger inhibitor, inhibits Na+-induced Ca2+ release from mitochondria in guinea pig heart with IC50 of 0.8 μM. |
靶点活性 | Na+, Ca2+ exchanger:0.8 μM |
体外活性 | Administration of 10?μM CGP37157 shows an inhibitory effect on mitochondrial Na+/Ca2+ exchanger in cortical neurons, modulating intracellular Ca2+ levels via suppressing voltage-gated calcium channels. Administration of 10?μM CGP37157 in combination with salinomycin significantly attenuates cell viability and increases apoptosis of FaDu and HLaC79 cells. CGP37157 has no inhibitory effect on salinomycin tumor toxicity[2]. Administration of 10?μM CGP37157 reduces NMDA-induced cytosolic and mitochondrial Ca2+ overloads and it also reduces NMDA-induced excitotoxicity, and such an effect is via attenuating mitochondrial damage and calpain activity in neurons[3]. |
别名 | 7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one |
分子量 | 324.22 |
分子式 | C15H11Cl2NOS |
CAS No. | 75450-34-9 |
Smiles | Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1 |
密度 | 1.384 g/cm3 (Predicted) |
存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 65 mg/mL (200.48 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容